Stock Analysis & Valuation Liminatus Pharma, Inc. Class A Common Stock (LIMN) Sector Valuation Confidence Level
High
Income Statement : Actual valuesActual As % of Revenue As % of Total Assets YoY Change (%)
Balance Sheet : Actual valuesActual As % of Total Assets As % of Revenue YoY Change (%)
Company Information 6 Centerpointe Drive
La Palma, CA 90623
United States
Industry: Biotechnology
Sector: Healthcare
CEO: Chris Kim
Full Time Employees: 3
Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.
Cash Flow Statement : Actual valuesActual As % of Revenue As % of Total Assets YoY Change (%)